Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Deterding · SciRah

Researcher profile · Semantic Scholar

K. Deterding

Share profile

K. Deterding — researcher profile on SciRah

h-index: 40
Works: 253
Citations: 5,726

Most-cited papers

Antiviral treatment and liver‐related complications in hepatitis delta
A. Wranke, B. Serrano, B. Heidrich, J. Kirschner +9 more
2017Hepatology115 citations Open access
Semantic Scholar
EASL position paper on clinical follow-up after HCV cure.
T. Reiberger, S. Lens, G. Cabibbo, P. Nahon +4 more
2024Journal of Hepatology76 citations
Semantic Scholar
Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity
B. Strunz, J. Hengst, K. Deterding, M. Manns +4 more
2018Nature Communications76 citations Open access
Semantic Scholar
Treating hepatitis D with bulevirtide - Real-world experience from 114 patients.
C. Dietz-Fricke, F. Tacke, C. Zöllner, M. Demir +38 more
2023JHEP Reports69 citations Open access
Semantic Scholar
Elimination of Hepatitis C Virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
Amare Aregay, S. Sekyere, K. Deterding, K. Port +6 more
2019Journal of Hepatology65 citations
Semantic Scholar
Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis
F. Mettke, B. Schlevogt, K. Deterding, A. Wranke +6 more
2018Alimentary Pharmacology and Therapeutics65 citations Open access
Semantic Scholar
Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection
A. Wranke, B. Heidrich, K. Deterding, K. Hupa-Breier +4 more
2023Hepatology International33 citations Open access
Semantic Scholar
HCC Immune Surveillance and Antiviral Therapy of Hepatitis C Virus Infection
Solomon Owusu Sekyere, B. Schlevogt, F. Mettke, M. Kabbani +7 more
2018Liver Cancer32 citations Open access
Semantic Scholar
Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antivirals
V. Pietsch, K. Deterding, D. Attia, K. Ringe +6 more
2018United European Gastroenterology journal31 citations Open access
Semantic Scholar
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case series
C. Dietz-Fricke, E. Degasperi, M. Jachs, B. Maasoumy +15 more
2024Hepatology29 citations Open access
Semantic Scholar
Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis—a randomized controlled trial
C. Ripoll, Stephanie Platzer, Philipp Franken, René Aschenbach +37 more
2023Trials29 citations Open access
Semantic Scholar
Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy
Sarina Ravens, J. Hengst, Verena Schlapphoff, K. Deterding +6 more
2018Frontiers in Immunology28 citations Open access
Semantic Scholar
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta.
M. Jachs, L. Sandmann, L. Hartl, T. Tergast +13 more
2024Journal of Hepatology27 citations
Semantic Scholar
HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta
L. Sandmann, C. Yurdaydın, K. Deterding, B. Heidrich +7 more
2021Hepatology Communications27 citations Open access
Semantic Scholar
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection
L. Sandmann, E. Degasperi, K. Port, S. Aleman +8 more
2024Alimentary Pharmacology and Therapeutics26 citations
Semantic Scholar
Beyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta.
K. Deterding, H. Wedemeyer
2019AIDS Reviews26 citations
Semantic Scholar
Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study
B. Maasoumy, P. Ingiliz, C. Spinner, C. Cordes +11 more
2022JHEP Reports23 citations Open access
Semantic Scholar
Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C
T. Khera, Yan-Qin Du, D. Todt, K. Deterding +11 more
2021Journal of Infectious Diseases23 citations Open access
Semantic Scholar
Incidence and clinical significance of recompensation after HCV-cure.
G. Semmler, S. Lens, Alvaro Hidalgo, S. Alonso-López +46 more
2025Clinical Gastroenterology and Hepatology22 citations Open access
Semantic Scholar
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections.
J. Dietz, U. Spengler, B. Müllhaupt, J. Schulze zur Wiesch +303 more
2019Clinical Gastroenterology and Hepatology20 citations Open access
Semantic Scholar
Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNA
K. Deterding, Cheng-Jian Xu, K. Port, C. Dietz-Fricke +4 more
2023Journal of Viral Hepatitis18 citations Open access
Semantic Scholar
Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients
Laura Scheller, G. Hilgard, O. Anastasiou, U. Dittmer +3 more
2021Medicine16 citations Open access
Semantic Scholar
Metabolic Dysfunction–Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus Panel
Yestle Kim, Peter Rydqvist, T. Ramezani, Jennifer S Haas +13 more
2025Liver international (Print)15 citations Open access
Semantic Scholar
Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection
J. Dietz, O. Kalinina, J. Vermehren, K. Peiffer +21 more
2020Journal of Viral Hepatitis15 citations Open access
Semantic Scholar
Intra-host analysis of hepaciviral glycoprotein evolution reveals signatures associated with viral persistence and clearance
André Gömer, Richard J. P. Brown, S. Pfaender, K. Deterding +9 more
2022Virus Evolution14 citations Open access
Semantic Scholar
Letter: a 5‐year long‐term follow‐up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis
Friederike Ebel, K. Deterding, K. Port, B. Schlevogt +4 more
2020Alimentary Pharmacology and Therapeutics13 citations Open access
Semantic Scholar
Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition
Melanie Urbanek-Quaing, Yin-Han Chou, M. Gupta, Katja Steppich +8 more
2024bioRxiv12 citations
Semantic Scholar
Real‐world effect of ribavirin on quality of life in HCV‐infected patients receiving interferon‐free treatment
C. Höner zu Siederdissen, B. Schlevogt, P. Solbach, K. Port +4 more
2018Liver international (Print)12 citations
Semantic Scholar
Kinetics and predictive value of HBcrAg, HBV RNA and anti‐HBc during bulevirtide treatment of chronic HDV‐infected patients
L. Sandmann, K. Deterding, B. Bremer, K. Port +3 more
2023Journal of Viral Hepatitis11 citations Open access
Semantic Scholar
T‐cell driven allergic cutaneous reaction complicating treatment of hepatitis delta virus infection with bulevirtide
P. Behrendt, S. Traidl, K. Böker, H. Wedemeyer +1 more
2022Liver international (Print)10 citations Open access
Semantic Scholar
Imprint of unconventional T‐cell response in acute hepatitis C persists despite successful early antiviral treatment
Yan-Qin Du, T. Khera, B. Strunz, K. Deterding +11 more
2021European Journal of Immunology10 citations Open access
Semantic Scholar
Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients
Solomon Owusu Sekyere, K. Port, K. Deterding, M. Cornberg +1 more
2020United European Gastroenterology journal10 citations Open access
Semantic Scholar
Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R)
J. Vermehren, Y. Serfert, M. Cornberg, A. Stoehr +10 more
2020Zeitschrift für Gastroenterologie - German Journal of Gastroenterology10 citations
Semantic Scholar
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients
J. Dietz, C. Graf, Christoph P. Berg, K. Port +20 more
2024JHEP Reports8 citations Open access
Semantic Scholar
Different kinetics of liver stiffness using shear wave elastography in patients with chronic hepatitis C infection treated with interferon-free regimens
D. Attia, K. Deterding, J. Cornberg, M. Gebel +4 more
2019European Journal of Gastroenterology and Hepathology8 citations
Semantic Scholar
TIGIT expression on natural killer cell subsets is an early indicator of alleviating liver inflammation following bulevirtide treatment in chronic hepatitis D
Po-Chun Chen, K. Deterding, S. Engelskircher, K. Port +12 more
2025Hepatology7 citations Open access
Semantic Scholar
Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infection
J. Hengst, Andreas Klein, S. Lunemann, K. Deterding +6 more
2018Journal of Viral Hepatitis7 citations
Semantic Scholar
Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis D
L. Sandmann, M. Jachs, T. Tergast, L. Hartl +15 more
2025JHEP Reports6 citations Open access
Semantic Scholar
Quality‐of‐life scores improve after 96 weeks of PEG‐IFNa‐2a treatment of hepatitis D: An analysis of the HIDIT‐II trial
K. Dinkelborg, J. Kahlhöfer, P. Dörge, C. Yurdaydın +27 more
2023Liver international (Print)6 citations Open access
Semantic Scholar
Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection
L. Sandmann, V. Ohlendorf, A. Ehrenbauer, Birgit Bremer +5 more
2025Liver international (Print)5 citations Open access
Semantic Scholar
Distinct inflammatory imprint in non-cirrhotic and cirrhotic patients before and after direct-acting antiviral therapy
Moana Witte, C. Oltmanns, J. Tauwaldt, Hagen Schmaus +11 more
2025Clinical and Molecular Hepatology5 citations Open access
Semantic Scholar
Letter to the Editor: The WHO HDV RNA international standard does not reflect variability of real-world samples.
L. Sandmann, Birgit Bremer, K. Deterding, K. Port +8 more
2024Hepatology5 citations Open access
Semantic Scholar
Antiviral Therapy of Chronic Hepatitis D Virus Infection – Addendum to the S3 Guideline “Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection” of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS)
L. Sandmann, T. Berg, K. Deterding, Nadine Fischer +4 more
2023Zeitschrift für Gastroenterologie - German Journal of Gastroenterology5 citations
Semantic Scholar
3P and 5P model of limited value for the detection of clinically significant portal hypertension in patients with hepatitis delta.
L. Sandmann, T. Tergast, H. Wedemeyer, K. Deterding +1 more
2023Journal of Hepatology5 citations
Semantic Scholar
Long-term follow-up after IFN-free therapy of advanced HCV-associated liver cirrhosis: continued improvement of liver function parameters – Results from the German Hepatitis C-Registry (DHC-R)
K. Deterding, S. Mauss, A. Pathil, P. Buggisch +13 more
20175 citations
Semantic Scholar
HBV Dominance Is Associated With a Distinct Inflammatory Milieu in HBV/HCV Coinfection
C. Oltmanns, Moana Witte, A. Wranke, K. Deterding +5 more
2025Journal of Viral Hepatitis4 citations Open access
Semantic Scholar
Predictors of undetectable hepatitis delta virus RNA at 48 weeks after end of treatment with bulevirtide monotherapy in the MYR301 study
S. Aleman, M. Brunetto, A. Blank, P. Andreone +17 more
2025Zeitschrift für Gastroenterologie - German Journal of Gastroenterology4 citations
Semantic Scholar
Final results of MYR301: a randomised phase 3 study evaluating the efficacy and safety of up to 144 weeks of bulevirtide monotherapy for chronic hepatitis Delta and 96 weeks of posttreatment follow-up
H. Wedemeyer, S. Aleman, A. Blank, P. Andreone +22 more
2025Zeitschrift für Gastroenterologie - German Journal of Gastroenterology4 citations
Semantic Scholar
Limited stability of Hepatitis B virus RNA in plasma and serum
V. Ohlendorf, B. Bremer, L. Sandmann, C. Mix +5 more
2024Scientific Reports4 citations Open access
Semantic Scholar
Bulevirtide treatment of hepatitis D in Germany: multicentre real-world experience
Christopher Dietz, F. Tacke, C. Zöllner, M. Demir +35 more
2022Journal of Hepatology4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Wedemeyer×25
Invite
H. Wedemeyer — researcher profile on SciRah
K. Port×19
Invite
K. Port — researcher profile on SciRah
M. Cornberg×19
Invite
M. Cornberg — researcher profile on SciRah
B. Maasoumy×16
Invite
B. Maasoumy — researcher profile on SciRah

×15

Invite

M. Manns — researcher profile on SciRah

L. Sandmann×11

Invite

L. Sandmann — researcher profile on SciRah

Markus Cornberg×7

Invite

Markus Cornberg — researcher profile on SciRah

Invite

S. Hardtke — researcher profile on SciRah

Heiner Wedemeyer×6

Invite

Heiner Wedemeyer — researcher profile on SciRah

Invite

B. Heidrich — researcher profile on SciRah

Invite

B. Bremer — researcher profile on SciRah

Invite

J. Hengst — researcher profile on SciRah